General
South African variant of COVID-19 can ‘break through’ Pfizer vaccine, Israeli study says
The coronavirus variant discovered in South Africa can “break through” the Pfizer COVID-19 vaccine to some extent, a real-world data study in Israel has found, though its prevalence in the country is low and the research has not been peer reviewed.
Key points:
The study, released on Saturday, compared almost 400 people who had tested positive for COVID-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated patients with the disease.
It matched age and gender, among other characteristics.
The South African variant, B.1.351, was found to make up about 1 per cent of all the COVID-19 cases across all the people studied, according to the study by Tel Aviv University and Israel’s largest…
-
Noosa News17 hours agoSunshine Butterflies 5th annual Walk in Wings returns to Noosa
-
Business13 hours agoHow to boost your superannuation in the final 10 years before retirement
-
Noosa News14 hours agoBaby boy killed and woman seriously injured after major crash on M1 at Gaven, Gold Coast
-
Noosa News15 hours agoWhale charity boss Brett Taylor allegedly ran euthanasia body ‘discovery service’